Investigator
Melanie Maria Ott
J. DAVID GLADSTONE INSTITUTES · funded by NIAID, NIDA
- Companies
- 4
- Grants
- 9
- Non-dilutive funding
- $11M
- First award
- Aug 17, 2018
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest May 11, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
ImmunologyGrant-only
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
NeuroGrant-only
- J. DAVID GLADSTONE INSTITUTESMomentum in another area
ImmunologyGrant-only
- J. DAVID GLADSTONE INSTITUTES36momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- P01
Organoid and Primary Culture Core
$325kMay 11, 2026NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11265555 (opens the source filing in a new tab)
- R61
Studying NeuroHIV and addictive substances in a human microglia-neuron chimera mouse model
$1.1MSep 1, 2025NIDAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11239620 (opens the source filing in a new tab)
- R01
Targeted small molecule recruitment to suppress the HIV transcriptionally active reservoir
$687kMay 15, 2025NIDAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11169612 (opens the source filing in a new tab)
- R01
Targeted small molecule recruitment to suppress the HIV transcriptionally active reservoir
$656kMay 15, 2025NIDAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11332984 (opens the source filing in a new tab)
- R37
Role of Factor Acetylation in the Regulation of HIV Transcription
$737kJul 1, 2024NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11064062 (opens the source filing in a new tab)
- R01
Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users
$1.6MSep 15, 2023NIDAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11146670 (opens the source filing in a new tab)
- UM1
HOPE - HIV Obstruction by Programmed Epigenetics
$5.0MAug 16, 2021NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11084564 (opens the source filing in a new tab)
- U19
PROJECT 2: Determine clinically relevant host-viral dependency networks for respiratory infections including SARS-CoV-2
$651kAug 17, 2018NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11088234 (opens the source filing in a new tab)
- U19
PROJECT 2: Determine clinically relevant host-viral dependency networks for respiratory infections including SARS-CoV-2
$649kAug 17, 2018NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11521637 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources